【结 构 式】 |
【分子编号】65626 【品名】N-Methyl-N-thiobenzoylhydrazine; Thiobenzoic acid 1-methylhydrazide 【CA登记号】21048-05-5 |
【 分 子 式 】C8H10N2S 【 分 子 量 】166.24688 【元素组成】C 57.8% H 6.06% N 16.85% S 19.29% |
合成路线1
该中间体在本合成路线中的序号:(III)Elesclomol can be prepared as follows. The precursor thiobenzoic acid N-methylhydrazide (III) can be obtained by either treatment of carboxymethyl dithiobenzoate (I) with methylhydrazine under alkaline conditions or by reaction of phenylmagnesium bromide (II) with carbon disulfide, followed by treatment with methylhydrazine. Then, dimerization of thiohydrazide (III) with malonic acid in the presence of DCC/HOBt, or with malonyl dichloride or malonic acid diphenyl ester, provides the target malonohydrazide derivative (1, 2). Conversion of elesclomol to different salts (including sodium, potassium, lithium, calcium, magnesium, ethanolamine and choline salts) has also been reported (3). Scheme 1.
【1】 Chen, S., Sun, L., Ono, M., Koya, K., Xia, Z.-Q. (SBR Pharmaceuticals Corp.). Synthesis of taxol enhancers. US 2003069225, US 6825235, WO 03006429. |
【2】 Koya, K., Sun, L., Ono, M., Tatsuta, N., Wu, Y., Chen, S. (Synta Pharmaceuticals Corp.). Taxol enhancer compounds. EP 1406869, EP 1731148, JP 2004534848, US 2003119914, WO 03006430. |
【3】 Kostik, E., Vaghefi, F., Liang, G. et al. (Synta Pharmaceuticals Corp.). EP 1781604, WO 2006009940. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 65625 | 2-(Benzothioylthio)acetic acid; S-(Thiobenzoyl)thioglycolic acid; Dithiobenzoic acid carboxymethyl ester | 942-91-6 | C9H8O2S2 | 详情 | 详情 |
(II) | 17616 | bromo(phenyl)magnesium; Phenyl Magnesium Bromide | 100-58-3 | C6H5BrMg | 详情 | 详情 |
(III) | 65626 | N-Methyl-N-thiobenzoylhydrazine; Thiobenzoic acid 1-methylhydrazide | 21048-05-5 | C8H10N2S | 详情 | 详情 |